Congratulations to Dr. John Hanna and Dr. Jessica Fortin who are the recipients of the 2021 Fred Sanfilippo-ASIP Visiting Lectureship.
The Fred Sanfilippo-ASIP Visiting Lectureship Program provides funding for ASIP members who are in the early stages of their academic careers to travel and visit other departments/institutions to give one or more research presentations as a distinguished visiting lecturer. The primary goal of this program is to provide exposure of promising young faculty to members of the greater pathobiology research community, increasing their national recognition and reputation. Fred Sanfilippo-ASIP Visiting Lecturers benefit from national exposure and interactions with faculty at the host institution which may result in new collaborations that will advance research endeavors at both institutions and may generate other beneficial long-term relationships such as distance mentoring within their chosen field of study.
ASIP members at academic institutions who are in the early stages of their career (Assistant Professors and/or Associate Professors who have not yet been granted tenure), are eligible for the Sanfilippo-ASIP Visiting Lectureship Program. Competitive nominees must have an established and productive research record and generally be a few years past their initial academic appointment. A nomination for the Fred Sanfilippo-ASIP Visiting Lectureship program can be initiated by the individual researcher, their department chair, or the host department chair. Required elements of nomination packages can be found here. For more information on this program or to initiate a nomination, please contact email@example.com.
About Dr. Fred Sanfilippo
Alfred P. (Fred) Sanfilippo, MD, PhD, is currently Professor of Pathology and Laboratory Medicine in the Emory University School of Medicine, Professor of Health Policy and Management in the Emory University Rollins School of Public Health, the Director of the Emory-Georgia Tech Healthcare Innovation Program, and Medical Director of the Marcus Foundation. Dr. Sanfilippo previously served Emory University as Executive Vice President for Health Affairs, Chief Executive Officer of the Robert W. Woodruff Health Science Center, and Chair of the Board of Directors for Emory Healthcare. In his earlier career, Dr. Sanfilippo served as a faculty member at Duke University (where he became Professor of Pathology, Experimental Surgery, and Immunology), Johns Hopkins University (where he served as Chair of the Department of Pathology), and The Ohio State University (where he served as Dean of the College of Medicine and Public Health, Senior Vice President and Executive Dean for Health Sciences, and CEO of the OSU Medical Center). Dr. Sanfilippo’s well-funded research programs have focused on the immunopathology of allograft rejection, receiving >$30M in funding and resulting in 3 patents, >225 original articles, 54 reviews, and 35 book chapters published to date. Dr. Sanfilippo served the ASIP from 1993-2003 as a representative to FASEB, 1996-2004 as a member of the ASIP Council, and as ASIP President in 2002-2003.